NCT02279511View on ClinicalTrials.gov

ATP in Alzheimer Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Alzheimer's Disease
Interventions
DRUG

ADENOSINE TRIPHOSPHATE

Infusion of 2.5g of ATP in 500 mL of saline solution. (IV)

DRUG

PLACEBO

Infusion of 500 mL of saline solution. (IV)

Trial Locations (2)

08028

Fundació ACE, Barcelona

Unknown

Hospital Sanitas CIMA, Barcelona

All Listed Sponsors
lead

Sara Varea

OTHER

NCT02279511 - ATP in Alzheimer Disease | Biotech Hunter | Biotech Hunter